- call +1-201-465-4211
- email sales@mrinsights.biz
Enteral access is the process by which nutrition is delivered to the patient. It is usually used in hospitalized patients; in this process, liquid supplements or daily requirements are fed to the patient with the help of a tube.
Scope of the Report:
Factors such as presence of postoperative patients with limited oral intake, increasing incidences of severe pancreatitis and chronic diseases, increasing geriatric population, technological advancements, and higher immature births drive the market growth.
Moreover, increasing RandD investments and untapped market opportunities in developing countries increase opportunities for the market growth.
The worldwide market for Infection Prevention and Enteral Access is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
This report focuses on the Infection Prevention and Enteral Access in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Cook Medical Inc
Medtronic plc
Boston Scientific Corporation
CONMED Corporation
CORPAK MedSystems
CR Bard, Inc
ALCOR Scientific Inc
Pacific Hospital Supply Co., Ltd
Teleflex Incorporated
Vygon SA
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Enteral Feeding Pumps
Enteral Feeding Tubes
Administration Reservoirs
Giving Sets
Enteral Syringes
Market Segment by Applications, can be divided into
Oncology
Gastroenterology
Diabetes
Neurological Disorders
Hypermetabolism
Others
There are 15 Chapters to deeply display the global Infection Prevention and Enteral Access market.
Chapter 1, to describe Infection Prevention and Enteral Access Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Infection Prevention and Enteral Access, with sales, revenue, and price of Infection Prevention and Enteral Access, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Infection Prevention and Enteral Access, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Infection Prevention and Enteral Access market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Infection Prevention and Enteral Access sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Infection Prevention and Enteral Access Introduction
1.2 Market Analysis by Type
1.2.1 Enteral Feeding Pumps
1.2.2 Enteral Feeding Tubes
1.2.3 Administration Reservoirs
1.2.4 Giving Sets
1.2.5 Enteral Syringes
1.3 Market Analysis by Applications
1.3.1 Oncology
1.3.2 Gastroenterology
1.3.3 Diabetes
1.3.4 Neurological Disorders
1.3.5 Hypermetabolism
1.3.6 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Cook Medical Inc
2.1.1 Business Overview
2.1.2 Infection Prevention and Enteral Access Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Cook Medical Inc Infection Prevention and Enteral Access Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Medtronic plc
2.2.1 Business Overview
2.2.2 Infection Prevention and Enteral Access Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Medtronic plc Infection Prevention and Enteral Access Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Boston Scientific Corporation
2.3.1 Business Overview
2.3.2 Infection Prevention and Enteral Access Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Boston Scientific Corporation Infection Prevention and Enteral Access Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 CONMED Corporation
2.4.1 Business Overview
2.4.2 Infection Prevention and Enteral Access Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 CONMED Corporation Infection Prevention and Enteral Access Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 CORPAK MedSystems
2.5.1 Business Overview
2.5.2 Infection Prevention and Enteral Access Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 CORPAK MedSystems Infection Prevention and Enteral Access Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 CR Bard, Inc
2.6.1 Business Overview
2.6.2 Infection Prevention and Enteral Access Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 CR Bard, Inc Infection Prevention and Enteral Access Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 ALCOR Scientific Inc
2.7.1 Business Overview
2.7.2 Infection Prevention and Enteral Access Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 ALCOR Scientific Inc Infection Prevention and Enteral Access Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Pacific Hospital Supply Co., Ltd
2.8.1 Business Overview
2.8.2 Infection Prevention and Enteral Access Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Pacific Hospital Supply Co., Ltd Infection Prevention and Enteral Access Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Teleflex Incorporated
2.9.1 Business Overview
2.9.2 Infection Prevention and Enteral Access Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Teleflex Incorporated Infection Prevention and Enteral Access Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Vygon SA
2.10.1 Business Overview
2.10.2 Infection Prevention and Enteral Access Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Vygon SA Infection Prevention and Enteral Access Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Infection Prevention and Enteral Access Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Infection Prevention and Enteral Access Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Infection Prevention and Enteral Access Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Infection Prevention and Enteral Access Manufacturer Market Share in 2017
3.3.2 Top 6 Infection Prevention and Enteral Access Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Infection Prevention and Enteral Access Market Analysis by Regions
4.1 Global Infection Prevention and Enteral Access Sales, Revenue and Market Share by Regions
4.1.1 Global Infection Prevention and Enteral Access Sales and Market Share by Regions (2013-2018)
4.1.2 Global Infection Prevention and Enteral Access Revenue and Market Share by Regions (2013-2018)
4.2 North America Infection Prevention and Enteral Access Sales and Growth Rate (2013-2018)
4.3 Europe Infection Prevention and Enteral Access Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Infection Prevention and Enteral Access Sales and Growth Rate (2013-2018)
4.5 South America Infection Prevention and Enteral Access Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Infection Prevention and Enteral Access Sales and Growth Rate (2013-2018)
5 North America Infection Prevention and Enteral Access by Countries
5.1 North America Infection Prevention and Enteral Access Sales, Revenue and Market Share by Countries
5.1.1 North America Infection Prevention and Enteral Access Sales and Market Share by Countries (2013-2018)
5.1.2 North America Infection Prevention and Enteral Access Revenue and Market Share by Countries (2013-2018)
5.2 United States Infection Prevention and Enteral Access Sales and Growth Rate (2013-2018)
5.3 Canada Infection Prevention and Enteral Access Sales and Growth Rate (2013-2018)
5.4 Mexico Infection Prevention and Enteral Access Sales and Growth Rate (2013-2018)
6 Europe Infection Prevention and Enteral Access by Countries
6.1 Europe Infection Prevention and Enteral Access Sales, Revenue and Market Share by Countries
6.1.1 Europe Infection Prevention and Enteral Access Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Infection Prevention and Enteral Access Revenue and Market Share by Countries (2013-2018)
6.2 Germany Infection Prevention and Enteral Access Sales and Growth Rate (2013-2018)
6.3 UK Infection Prevention and Enteral Access Sales and Growth Rate (2013-2018)
6.4 France Infection Prevention and Enteral Access Sales and Growth Rate (2013-2018)
6.5 Russia Infection Prevention and Enteral Access Sales and Growth Rate (2013-2018)
6.6 Italy Infection Prevention and Enteral Access Sales and Growth Rate (2013-2018)
7 Asia-Pacific Infection Prevention and Enteral Access by Countries
7.1 Asia-Pacific Infection Prevention and Enteral Access Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Infection Prevention and Enteral Access Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Infection Prevention and Enteral Access Revenue and Market Share by Countries (2013-2018)
7.2 China Infection Prevention and Enteral Access Sales and Growth Rate (2013-2018)
7.3 Japan Infection Prevention and Enteral Access Sales and Growth Rate (2013-2018)
7.4 Korea Infection Prevention and Enteral Access Sales and Growth Rate (2013-2018)
7.5 India Infection Prevention and Enteral Access Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Infection Prevention and Enteral Access Sales and Growth Rate (2013-2018)
8 South America Infection Prevention and Enteral Access by Countries
8.1 South America Infection Prevention and Enteral Access Sales, Revenue and Market Share by Countries
8.1.1 South America Infection Prevention and Enteral Access Sales and Market Share by Countries (2013-2018)
8.1.2 South America Infection Prevention and Enteral Access Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Infection Prevention and Enteral Access Sales and Growth Rate (2013-2018)
8.3 Argentina Infection Prevention and Enteral Access Sales and Growth Rate (2013-2018)
8.4 Colombia Infection Prevention and Enteral Access Sales and Growth Rate (2013-2018)
9 Middle East and Africa Infection Prevention and Enteral Access by Countries
9.1 Middle East and Africa Infection Prevention and Enteral Access Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Infection Prevention and Enteral Access Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Infection Prevention and Enteral Access Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Infection Prevention and Enteral Access Sales and Growth Rate (2013-2018)
9.3 UAE Infection Prevention and Enteral Access Sales and Growth Rate (2013-2018)
9.4 Egypt Infection Prevention and Enteral Access Sales and Growth Rate (2013-2018)
9.5 Nigeria Infection Prevention and Enteral Access Sales and Growth Rate (2013-2018)
9.6 South Africa Infection Prevention and Enteral Access Sales and Growth Rate (2013-2018)
10 Global Infection Prevention and Enteral Access Market Segment by Type
10.1 Global Infection Prevention and Enteral Access Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Infection Prevention and Enteral Access Sales and Market Share by Type (2013-2018)
10.1.2 Global Infection Prevention and Enteral Access Revenue and Market Share by Type (2013-2018)
10.2 Enteral Feeding Pumps Sales Growth and Price
10.2.1 Global Enteral Feeding Pumps Sales Growth (2013-2018)
10.2.2 Global Enteral Feeding Pumps Price (2013-2018)
10.3 Enteral Feeding Tubes Sales Growth and Price
10.3.1 Global Enteral Feeding Tubes Sales Growth (2013-2018)
10.3.2 Global Enteral Feeding Tubes Price (2013-2018)
10.4 Administration Reservoirs Sales Growth and Price
10.4.1 Global Administration Reservoirs Sales Growth (2013-2018)
10.4.2 Global Administration Reservoirs Price (2013-2018)
10.5 Giving Sets Sales Growth and Price
10.5.1 Global Giving Sets Sales Growth (2013-2018)
10.5.2 Global Giving Sets Price (2013-2018)
10.6 Enteral Syringes Sales Growth and Price
10.6.1 Global Enteral Syringes Sales Growth (2013-2018)
10.6.2 Global Enteral Syringes Price (2013-2018)
11 Global Infection Prevention and Enteral Access Market Segment by Application
11.1 Global Infection Prevention and Enteral Access Sales Market Share by Application (2013-2018)
11.2 Oncology Sales Growth (2013-2018)
11.3 Gastroenterology Sales Growth (2013-2018)
11.4 Diabetes Sales Growth (2013-2018)
11.5 Neurological Disorders Sales Growth (2013-2018)
11.6 Hypermetabolism Sales Growth (2013-2018)
11.7 Others Sales Growth (2013-2018)
12 Infection Prevention and Enteral Access Market Forecast (2018-2023)
12.1 Global Infection Prevention and Enteral Access Sales, Revenue and Growth Rate (2018-2023)
12.2 Infection Prevention and Enteral Access Market Forecast by Regions (2018-2023)
12.2.1 North America Infection Prevention and Enteral Access Market Forecast (2018-2023)
12.2.2 Europe Infection Prevention and Enteral Access Market Forecast (2018-2023)
12.2.3 Asia-Pacific Infection Prevention and Enteral Access Market Forecast (2018-2023)
12.2.4 South America Infection Prevention and Enteral Access Market Forecast (2018-2023)
12.2.5 Middle East and Africa Infection Prevention and Enteral Access Market Forecast (2018-2023)
12.3 Infection Prevention and Enteral Access Market Forecast by Type (2018-2023)
12.3.1 Global Infection Prevention and Enteral Access Sales Forecast by Type (2018-2023)
12.3.2 Global Infection Prevention and Enteral Access Market Share Forecast by Type (2018-2023)
12.4 Infection Prevention and Enteral Access Market Forecast by Application (2018-2023)
12.4.1 Global Infection Prevention and Enteral Access Sales Forecast by Application (2018-2023)
12.4.2 Global Infection Prevention and Enteral Access Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Infection Prevention and Enteral Access Picture
Table Product Specifications of Infection Prevention and Enteral Access
Figure Global Sales Market Share of Infection
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
